Zymeworks ZYME Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.41M-4.3% | $2.52M-90.9% | $27.61M-43.3% | $48.73M+79.7% | $27.11M-12.6% | ||
| $34.46M— | —— | $35.58M+3.3% | $34.45M-3.6% | $35.74M-3.6% | ||
| $15.07M-2.4% | $15.43M+9.1% | $14.15M-5.4% | $14.95M-12.0% | $16.99M+4.9% | ||
| $49.53M+6.1% | $46.67M-6.1% | $49.72M+0.7% | $49.4M-6.3% | $52.72M-1.0% | ||
| -$47.12M-6.7% | -$44.15M-99.7% | -$22.11M-3,180% | -$674K+97.4% | -$25.61M-15.3% | ||
| -1,956.7%-201pp | -1,755.5%-1,675pp | -80.1%-78.7pp | -1.4%+93.1pp | -94.5%-22.9pp | ||
| $2.71M-8.9% | $2.98M-15.7% | $3.53M+3.0% | $3.43M+0.1% | $3.42M-16.1% | ||
| $120K+140% | -$302K-196% | $315K+151% | -$621K-1,367% | $49K-85.8% | ||
| -$46.35M-11.8% | -$41.48M-127% | -$18.27M-957% | $2.13M+110% | -$22.14M-24.4% | ||
| -$2.19M— | —— | $1.34M+818% | -$186K-138% | $496K-91.3% | ||
| -$44.16M-7.2% | -$41.21M-110% | -$19.6M-946% | $2.32M+110% | -$22.64M+3.7% | ||
| -1,834%-195pp | -1,638.5%-1,568pp | -71%-75.7pp | 4.8%+88.3pp | -83.5%-7.7pp | ||
| -$0.59-7.3% | -$0.55-112% | -$0.26-967% | $0.03+110% | -$0.30+6.3% | ||
| -$45.98M-6.8% | -$43.07M-110% | -$20.56M-1,231% | $1.82M+108% | -$23.02M-19.8% | ||
| -1,909.4%-197pp | -1,712.5%-1,638pp | -74.4%-78.2pp | 3.7%+88.6pp | -84.9%-23.0pp | ||
| -$47.12M-6.7% | -$44.15M-99.7% | -$22.11M-3,180% | -$674K+97.4% | -$25.61M-15.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Zymeworks's income statement data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.